Fibrinolysis; Hemorrhage
6
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery